- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
- 10-K Annual report
- 10.12.2 Amendment No. 1 Dated November 11, 2009 to Sublease Agreement
- 10.12.3 Amendment No. 2 Dated February 19, 2010 to Sublease Agreement
- 21.1 List of Subdidiaries of Myriad Genetics, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the CEO Pursuant to Section 302
- 31.2 Certification of the CFO Pursuant to Section 302
- 32 Certification of the CEO & CFO Pursuant to Section 906
Exhibit 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 10-K for the year ended June 30, 2010 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 12, 2010 | Date: August 12, 2010 | |||
| /s/ Peter D. Meldrum | /s/ James S. Evans | |||
| Peter D. Meldrum | James S. Evans | |||
| President and Chief Executive Officer | Chief Financial Officer | |||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.